7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

PaxMedica, Inc.
(NASDAQ:PXMD) 

PXMD stock logo

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indi...

Founded: 2018
IPO Price: $5.25 (Aug 26, 2022)
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
PaxMedica . Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -292.26-250.51-208.75-167-125.25-83.5-41.750
PaxMedica . Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -292.26-250.51-208.75-167-125.25-83.5-41.750
PaxMedica . Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 086.6173.19259.79346.39432.99519.58606.18
PaxMedica . (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -14.78-10.02-5.26-0.54.259.0113.7718.53
PaxMedica . P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.4211.629.6247.6465.6683.68101.7119.72
No extra charts and metrics for this ticker.